Table of Contents
Organic Chemistry International
Volume 2012 (2012), Article ID 293945, 5 pages
http://dx.doi.org/10.1155/2012/293945
Research Article

Preparation and Structure of Novel Chiral 4,6-Disubstituted Tetrahydropyrimidinones

School of Chemistry, National University of Ireland, University Road, Galway, Ireland

Received 9 July 2012; Accepted 11 October 2012

Academic Editor: Ken Shimizu

Copyright © 2012 David Frain et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. L. Adams, T. D. Meek, S. M. Mong, R. K. Johnson, and B. W. Metcalf, “cis-4-carboxy-6-(mercaptomethyl)-3,4,5,6-tetrahydropyrimidin-2(1H)-one, a potent inhibitor of mammalian dihydroorotase,” Journal of Medicinal Chemistry, vol. 31, no. 7, pp. 1355–1359, 1988. View at Google Scholar · View at Scopus
  2. H. O. Andersson, K. Fridborg, S. Löwgren et al., “Optimization of P1–P3 groups in symmetric and asymmetric HIV-1 protease inhibitors,” European Journal of Biochemistry, vol. 270, no. 8, pp. 1746–1758, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. M. E. Pierce, G. D. Harris, Q. Islam et al., “Stereoselective synthesis of HIV-1 protease inhibitor, DMP 323,” The Journal of Organic Chemistry, vol. 61, no. 2, pp. 444–450, 1996. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Gayathri, V. Pande, R. Sivakumar, and S. P. Gupta, “A quantitative structure-activity relationship study on some HIV-1 protease inhibitors using molecular connectivity index,” Bioorganic and Medicinal Chemistry, vol. 9, no. 11, pp. 3059–3063, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. A. R. Katritzky, A. Oliferenko, A. Lomaka, and M. Karelson, “Six-membered cyclic ureas as HIV-1 protease inhibitors: a QSAR study based on CODESSA PRO approach,” Bioorganic and Medicinal Chemistry Letters, vol. 12, no. 23, pp. 3453–3457, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Pelosi and Salvatore Jr., “Novel cyclic ureas useful as antiarrythmic and antifibrillatory agents,” WO 93/04060, 1993. View at Google Scholar
  7. D. W. Pettigrew, R. R. Bidigare, B. J. Mehta, M. I. Williams, and E. G. Sander, “Dihydro-orotase from Clostridium oroticum. Purification and reversible removal of essential zinc,” Biochemical Journal, vol. 230, no. 1, pp. 101–108, 1985. View at Google Scholar · View at Scopus
  8. R. Garg and B. Bhhatarai, “A mechanistic study of 3-aminoindazole cyclic urea HIV-1 protease inhibitors using comparative QSAR,” Bioorganic and Medicinal Chemistry, vol. 12, no. 22, pp. 5819–5831, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. C. N. Hodge, P. E. Aldrich, L. T. Bacheler et al., “Improved cyclic urea inhibitors of the HIV-1 protease: synthesis, potency, resistance profile, human pharmacokinetics and X-ray crystal structure of DMP 450,” Chemistry and Biology, vol. 3, no. 4, pp. 301–314, 1996. View at Google Scholar · View at Scopus
  10. P. Y. S. Lam, Y. Ru, P. K. Jadhav et al., “Cyclic HIV protease inhibitors: synthesis, conformational analysis, P2/P2' structure-activity relationship, and molecular recognition of cyclic ureas,” Journal of Medicinal Chemistry, vol. 39, no. 18, pp. 3514–3525, 1996. View at Publisher · View at Google Scholar · View at Scopus
  11. F. Qian, J. E. McCusker, Y. Zhang et al., “Catalytic oxidative carbonylation of primary and secondary diamines to cyclic ureas. Optimization and substituent studies,” The Journal of Organic Chemistry, vol. 67, no. 12, pp. 4086–4092, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. J. Kim and R. S. Varma, “Microwave-assisted preparation of cyclic ureas from diamines in the presence of ZnO,” Tetrahedron Letters, vol. 45, no. 39, pp. 7205–7208, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. W. R. Boon, “Respiratory stimulants. Part I. Fully-substituted ureas derived from αω-alkylenediamines,” Journal of the Chemical Society, pp. 307–318, 1947. View at Google Scholar · View at Scopus
  14. D. Frain, F. Kirby, P. McArdle, and P. O'Leary, “The synthesis of AraBOX, a new 4,4-bis(oxazoline), from novel pentitol-derived bis-β-amino alcohols,” Synlett, no. 8, pp. 1261–1264, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. D. Frain, F. Kirby, P. McArdle, and P. O'Leary, “Preparation, structure and catalytic activity of copper(II) complexes of novel 4,4′-BOX ligands,” Tetrahedron Letters, vol. 51, no. 31, pp. 4103–4106, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. F. Kirby, D. Frain, P. McArdle, and P. O'Leary, “4,4′BOX based catalysts: synthesis, structure and catalytic application,” Catalysis Communications, vol. 11, no. 12, pp. 1012–1016, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. “The CIF files for compound 9 has been deposited with the The Cambridge Crystallographic Data Centre (deposition number CCDC, 800917)”.
  18. N. Blagden, R. Davey, G. Dent et al., “Woehler and Liebig revisited: a small molecule reveals its secrets—the crystal structure of the unstable polymorph of benzamide solved after 173 years,” Crystal Growth and Design, vol. 5, no. 6, pp. 2218–2224, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Calogero, U. Russo, and A. Del Pra', “Characterization of some high-spin iron(III) complexes with urea derivaties. Crystal structure of diaquatetrakis(perhydropyrimidin-2-one)iron trichloride dihydrate and of perhydrophyrimidin-2-one,” Journal of the Chemical Society, Dalton Transactions, pp. 646–653, 1980. View at Publisher · View at Google Scholar · View at Scopus
  20. “Testing was carried out by CEREP inc France”.